| Product ID |
Product Name |
CAS# |
Purity |
| Y4011916 |
ergost-7,22-diene-3-ol |
32507-77-0 |
95.0% |
| Y4011917 |
2(3H)-Naphthalenone, 4,4a,5,6,7,8-hexahydro-7,8-dihydroxy-4a,8-dimethyl-, (4aR,7R,8R)- (9CI) |
363610-34-8 |
97.5% |
| Y4011915 |
INGENOL-20-HEXADECANOATE |
39071-33-5 |
97.0% |
| Y4011923 |
2-(4-Methylphenyl)-4-(trifluoromethyl)-1H-imidazole |
33469-18-0 |
95% |
| Y4011926 |
Lucialdehyde A |
420781-84-6 |
≥98% |
| Y4011927 |
jolkinolide A |
37905-07-0 |
97.5% |
| Y4011929 |
1-[4-(2-hydroxyethoxy)phenyl]ethanone |
31769-45-6 |
97% |
| Y4011930 |
1-(3-Chloro-4-(methylthio)phenyl)ethanone |
32467-66-6 |
95% |
| Y4011932 |
2-(3,4-Dihydroxyphenyl)-8-β-D-glucopyranosyl-5,7-dihydroxy-6-β-D-xylopyranosyl-4H-1-benzopyran-4-one |
35927-39-0 |
≥98% |
| Y4011935 |
(18α,19α)-3β-Hydroxyurs-20-en-16-one |
42482-69-9 |
≥98% |
| Y4011928 |
Tridecanamide |
34778-57-9 |
95% |
| Y4011934 |
natsudaidain |
35154-55-3 |
≥98% |
| Y4011940 |
sugereoside |
41743-57-1 |
Powder |
| Y4011938 |
1-(6-METHOXY-PYRIDIN-2-YL)-PIPERAZINE |
51047-54-2 |
96% |
| Y4011937 |
E,Z-3,13-OCTADECADIENYLACETATE |
53120-26-6 |
90% |
| Y4011941 |
5-BROMO-2-(1H-PYRROL-1-YL)PYRIMIDINE |
478258-70-7 |
97% |
| Y4011943 |
6-(cyclohexyloxy)nicotinic acid |
509101-15-9 |
95% |
| Y4011950 |
3-METHOXYPHENYL ACETATE |
5451-83-2 |
97% |
| Y4011948 |
1-(BENZYLOXY)-4-BROMO-2,5-DIMETHOXYBENZENE |
524713-43-7 |
97% |
| Y4011947 |
3',5'-DIMETHYLBIPHENYL-4-CARBOXYLIC ACID |
505082-92-8 |
97% |
| Y4011949 |
4-(5-NITRO-2-PYRIDINYL)BENZENECARBALDEHYDE |
433920-97-9 |
97% |
| Y4011956 |
N,N-dimethyl-4-prop-2-enyl-aniline |
51601-26-4 |
96% |
| Y4011955 |
Methyl 2-(hex-1-yn-1-yl)benzoate |
462637-40-7 |
95%+ |
| Y4011964 |
5-CHLORO-1-(2-METHOXYPHENYL)-1-OXOPENTANE |
43228-96-2 |
95% |
| Y4011963 |
2,3,5,6-TETRAFLUOROIODOBENZENE |
5243-24-3 |
97% |
| Y4011959 |
(4aS,10aS)-6-hydroxy-1,1,4a-trimethyl-7-propan-2-yl-3,4,10,10a-tetrahy dro-2H-phenanthren-9-one |
511-05-7 |
≥98% |
| Y4011967 |
Benzonitrile, 2-(2-methoxyethoxy)- (9CI) |
540753-14-8 |
97% |
| Y4011968 |
N-benzyl-4-methyl-benzamide |
5436-83-9 |
97% |
| Y4011969 |
3-methyl-N,N-dipropan-2-yl-benzamide |
5448-36-2 |
95% |
| Y4011970 |
2-[(4-methylbenzyl)oxy]benzoic acid |
52803-45-9 |
97% |
| Y4011974 |
4-ETHOXY-2-FLUOROBENZALDEHYDE |
532965-74-5 |
97% |
| Y4011973 |
6-chloro-3-methyl-indazole |
55774-25-9 |
95% |
| Y4011972 |
4-(4-broMo-2-chlorobenzyl)Morpholine |
494773-04-5 |
96% |
| Y4011939 |
Calcium 3-hydroxybutyrate |
51899-07-1 |
95%+ |
| Y4011979 |
Benzonitrile, 4-[(E)-(hydroxyimino)methyl]- (9CI) |
52707-54-7 |
97% |
| Y4011980 |
Cadambine |
54422-49-0 |
98.0% |
| Y4011975 |
CHAETOGLOBOSINC |
50645-76-6 |
≥95% |
| Y4011982 |
3-Dibenzofurancarbaldehyde |
51818-91-8 |
95% |
| Y4012588 |
1-METHOXY-2-METHYL-4-(METHYLTHIO)BENZENE, 97 |
50390-78-8 |
97% |
| Y4012586 |
N-Acetyl-L-norleucyl-L-alanyl-L-histidyl-D-phenylalanyl-L-arginyl-L-tryptophanamide |
448944-47-6 |
≥98% |
| Y4012587 |
4-n-butylbutyrophenone |
55919-43-2 |
95% |
| Y4012590 |
CYS-TYR-ILE-THR-ASN-CYS-GLY-LEU-GLY-NH2 |
60786-59-6 |
99% |
| Y4011899 |
2-AMINO-5-CHLORO-BENZOIC ACID ETHYL ESTER |
63243-75-4 |
97% |
| Y4012594 |
TFA-VAL-TYR-VAL-OH |
64577-63-5 |
95% |
| Y4012596 |
1,4-DIMETHOXY-2-METHYLTHIOBENZENE |
61638-04-8 |
97% |
| Y4012595 |
21-Dehydro-6α-Methyl Prednisolone |
58636-50-3 |
95% |
| Y4012602 |
Longistylin C |
64125-60-6 |
98.5% |
| Y4012603 |
Momor-cerebroside I |
606125-07-9 |
95.0% |
| Y4012604 |
6-Hydroxy-8,8-dimethyl-2H,8H-benzo[1,2-b |
60796-64-7 |
98.0% |
| Y4012601 |
Tagitinin A |
59979-61-2 |
98.0% |
| Y4012615 |
N-(5-BROMO-2-PYRIDINYL)-BENZAMIDE |
62802-75-9 |
97% |
| Y4012621 |
1-(5-bromobenzofuran-2-yl)ethanol |
592542-03-5 |
95% |
| Y4012608 |
2-tert-Butoxy-4-methylpyridine |
57883-15-5 |
97% |
| Y4012616 |
1a,1b,2,3,4,5,7a,8,8a,9,10,10a-Dodecahydro-2-hydroxy-6-(hydroxymethyl) -3,8,8,10a-tetramethyl-5-oxo-4aH-cyclopenta(3,4)cyclopropa(8,9)cycloun dec(1,2-b)oxiren-4a-yl ester |
62820-11-5 |
96.0% |
| Y4012620 |
4-Fluoro-3-iodobenzoic acid ethyl ester |
618-93-9 |
95% |
| Y4012610 |
(4'-Methylbiphenyl-4-yl)(phenyl)methanone |
63283-56-7 |
97% |
| Y4012609 |
5-PyriMidinecarboxylicacid, 2-(diMethylaMino)-, ethyl ester |
64224-68-6 |
97% |
| Y4012619 |
4-(4-Fluoro-3-methoxyphenyl)phenol |
64465-63-0 |
98% |
| Y4012626 |
alpha-cyclopropyl-4-methylbenzyl alcohol |
6552-46-1 |
97% |
| Y4012625 |
2-cyclohexylpiperidine |
56528-77-9 |
95% |
| Y4012627 |
Ethanone, 2-chloro-1-(3-chloro-2-methylphenyl)- (9CI) |
60988-74-1 |
95% |
| Y4012630 |
MARITIMETIN |
576-02-3 |
≥98% |
| Y4011879 |
GD2-GANGLIOSIDE |
65988-71-8 |
95%+ |
| Y4012637 |
ACTH (34-39) |
69454-10-0 |
99.82% |
| Y4012632 |
4-BROMO DIPHENYL SULFIDE |
65662-88-6 |
95% |
| Y4012634 |
3-(2-CHLOROETHOXY)-BROMOBENZENE |
730978-54-8 |
97% |
| Y4012643 |
IsoliMonexic acid |
73904-93-5 |
98.0% |
| Y4012645 |
4-BROMO-3'-METHOXYBIPHENYL |
74447-69-1 |
95% |
| Y4012644 |
4'-PHENOXY-2,2,2-TRIFLUOROACETOPHENONE |
70783-32-3 |
96% |
| Y4012655 |
Cyclopropyl-(2,5-dimethylphenyl)methanone |
71172-44-6 |
97% |
| Y4012647 |
(13S)-10-Demethyl-9α-methylpimarane-5α,15,16-triol |
7121-99-5 |
98.0% |
| Y4012648 |
2-Naphthaleneacetic acid,1,2,3,4,4a,5,6,7-octahydro-4a,8-dimethyl-a-methylene-, (2R,4aR)- |
69978-82-1 |
96.0% |
| Y4012649 |
9-HYDROXY-3-METHOXYPTEROCARPIN |
74560-05-7 |
99.0% |
| Y4012651 |
MANNOTRIOSE-DI-(N-ACETYL-D-GLUCOSAMINE), BIS(GALACTOSYL-[N-ACETYL-D-GLUCOSAMINYL]) |
71496-53-2 |
95.0% |
| Y4012663 |
3-Pyridinamine,2-(4-methoxyphenyl)-(9CI) |
663918-44-3 |
97% |
| Y4012660 |
Methyl vanillate glucoside |
72500-11-9 |
98.5% |
| Y4012661 |
Glucyrin |
66056-18-6 |
98% |
| Y4012662 |
1,2-Bis(4-bromophenyl)ethanone |
7150-10-9 |
95% |
| Y4012666 |
4-Chloroisoquinolin-3-aMine |
66729-00-8 |
95% |
| Y4012671 |
Ethanone, 2,2-difluoro-1-(1-naphthalenyl)- (9CI) |
715-80-0 |
97% |
| Y4012669 |
1-(2-ETHOXY-4-METHOXY-PHENYL)-ETHANONE |
67082-94-4 |
95% |
| Y4012675 |
2,2,2-trifluoro-1-[4-(morpholin-4-yl)phenyl]ethan-1-one |
70783-44-7 |
97% |
| Y4012677 |
PIPERMETHYSTINE |
71627-22-0 |
≥98% |
| Y4012691 |
4-TERT-BUTYL-3'-METHYLBENZHYDROL |
842140-68-5 |
97% |
| Y4012699 |
N-methyl-1-(5-methyl-2-thienyl)methanamine |
82230-49-7 |
97% |
| Y4012698 |
Labetalol IMpurity B |
802620-01-5 |
95% |
| Y4012703 |
[3-[[[2-(DiaMinoMethyleneaMino)-4-thiazolyl]Methyl]thio]propionyl]sulfaMide Hydrochloride(FaMotidine IMpurity) |
76824-17-4 |
95% |
| Y4012706 |
4-n-butylpropiophenone |
79219-21-9 |
97% |
| Y4012693 |
Dehydro-δ-tocopherol |
802909-72-4 |
97.5% |
| Y4011889 |
Kobusone |
24173-71-5 |
90.0% |
| Y4011887 |
serrat-14-ene-3,21-diol |
2239-24-9 |
Powder |
| Y4011891 |
Sitosteryl palmitate |
2308-85-2 |
90.0% |
| Y4011892 |
Zamanic acid |
260393-05-3 |
95.0% |
| Y4011894 |
2-(METHYLTHIO)NICOTINONITRILE |
219766-02-6 |
95% |
| Y4011900 |
2-Chloro-3-N,N-diethyl-pyridinecarboxamide |
38029-99-1 |
97% |
| Y4011081 |
methyl valerimidate hydrochloride |
39739-46-3 |
95% |
| Y4011901 |
ETHYL 2-(1-NAPHTHYL)-2-OXOACETATE |
33656-65-4 |
96% |
| Y4011897 |
cyclohexyl m-tolyl ketone |
3277-78-9 |
97% |
| Y4011898 |
ETHYL 4-BROMO-2-METHYLBENZOYLFORMATE |
383363-34-6 |
96% |
| Y4011909 |
5-(TRIFLUOROMETHYL)-3-(4-METHOXYPHENYL)-1H-PYRAZOLE |
380905-15-7 |
95% |